XML 72 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Information (Tables)
 12 Months Ended
Dec. 31, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Condensed Consolidating Statements of Income
Condensed Consolidating Statements of Income
(In millions)
For the year ended December 31, 2018CignaOld Cigna Express Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Revenues
Premiums$-$-$-$-$-$36,113$-$36,113
Fees and other revenues---2375,596(48)5,578
Pharmacy revenues---1,8664184,165(970)5,479
Net investment income12312--1,354-1,480
Total revenues123121,88942547,228(1,018)48,650
Benefits and expenses
Medical costs and other benefit expenses-----27,528-27,528
Pharmacy and other service costs---1,7634173,583(970)4,793
Selling, general and administrative expenses200535-44811,195(48)11,934
Amortization of acquired intangible assets---9413128-235
Total benefits and expenses200535-1,90143842,434(1,018)44,490
Income (loss) from operations(77)(534)2(12)(13)4,794-4,160
Interest and other income (expense)(244)(264)15(17)(10)22-(498)
Intercompany interest income (expense)(5)(58)(15)7566--
Net realized investment (losses)(1)----(80)-(81)
Income (loss) before income taxes(327)(856)2(22)(18)4,802-3,581
Total income tax (benefit) expense(74)(163)-(4)(4)1,180-935
Income (loss) before equity in earnings of subsidiaries(253)(693)2(18)(14)3,622-2,646
Equity in earnings (loss) of subsidiaries2,8903,613(32)(33)29-(6,467)-
Net income (loss)2,6372,920(30)(51)153,622(6,467)2,646
Less: Net income attributable to noncontrolling interests-----9-9
Shareholders' net income (loss) $ 2,637 $ 2,920 $ (30) $ (51) $ 15 $ 3,613 $ (6,467) $ 2,637
Other comprehensive (loss), net of tax(390)(390)---(536)926(390)
Shareholders' comprehensive income (loss) $ 2,247 $ 2,530 $ (30) $ (51) $ 15 $ 3,077 $ (5,541) $ 2,247

Condensed Consolidating Statements of Income
(In millions)
For the year ended December 31, 2017CignaOld Cigna Express Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Revenues
Premiums$-$-$-$-$-$32,491$-$32,491
Fees and other revenues-----5,110-5,110
Pharmacy revenues-----2,979-2,979
Net investment income-----1,226-1,226
Total revenues-----41,806-41,806
Benefits and expenses
Medical costs and other benefit expenses-----25,263-25,263
Pharmacy and other service costs-----2,456-2,456
Selling, general and administrative expenses-195---9,835-10,030
Amortization of acquired intangible assets-----115-115
Total benefits and expenses-195---37,669-37,864
Income (loss) from operations-(195)---4,137-3,942
Interest and other (expense)-(246)---(6)-(252)
Intercompany interest income (expense)-(18)---18--
Debt extinguishment (costs)-(321)-----(321)
Net realized investment gains-----237-237
Income (loss) before income taxes-(780)---4,386-3,606
Total income tax (benefit) expense-(194)---1,568-1,374
Income (loss) before equity in earnings of subsidiaries-(586)---2,818-2,232
Equity in earnings of subsidiaries-2,823----(2,823)-
Net income-2,237---2,818(2,823)2,232
Less: Net (loss) attributable to noncontrolling interests-----(5)-(5)
Shareholders' net income$-$2,237$-$-$-$2,823$(2,823)$2,237
Other comprehensive income, net of tax-300---269(269)300
Shareholders' comprehensive income$-$2,537$-$-$-$3,092$(3,092)$2,537

Condensed Consolidating Statements of Income
(In millions)
For the year ended December 31, 2016CignaOld Cigna Express Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Revenues
Premiums$-$-$-$-$-$30,824$-$30,824
Fees and other revenues-----4,901-4,901
Pharmacy revenues-----2,966-2,966
Net investment income-----1,147-1,147
Total revenues-----39,838-39,838
Benefits and expenses
Medical costs and other benefit expenses-----24,341-24,341
Pharmacy and other service costs-----2,468-2,468
Selling, general and administrative expenses-281---9,509-9,790
Amortization of acquired intangible assets-----151-151
Total benefits and expenses-281---36,469-36,750
Income (loss) from operations-(281)---3,369-3,088
Interest and other (expense)-(244)---(34)-(278)
Intercompany interest income (expense)-(3)---3--
Net realized investment gains-----169-169
Income (loss) before income taxes-(528)---3,507-2,979
Total income tax (benefit) expense-(146)---1,282-1,136
Income (loss) before equity in earnings of subsidiaries-(382)---2,225-1,843
Equity in earnings of subsidiaries-2,249----(2,249)-
Net income-1,867---2,225(2,249)1,843
Less: Net (loss) attributable to noncontrolling interests-----(24)-(24)
Shareholders' net income$-$1,867$-$-$-$2,249$(2,249)$1,867
Other comprehensive (loss), net of tax-(132)---(154)154(132)
Shareholders' comprehensive income$-$1,735$-$-$-$2,095$(2,095)$1,735
Condensed Consolidating Balance Sheets
Condensed Consolidating Balance Sheets
(In millions)
As of December 31, 2018CignaOld CignaExpress Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Assets
Cash and cash equivalents$243$-$633$43$-$2,936$-$3,855
Investments-----2,045-2,045
Accounts receivable, net---4,2067485,519-10,473
Inventories-----2,821-2,821
Other current assets1459-310-1,063(210)1,236
Total current assets257596334,55974814,384(210)20,430
Long-term investments-10---26,919-26,929
Reinsurance recoverables-----5,507-5,507
Deferred policy acquisition costs-----2,821-2,821
Property and equipment---2,432-2,130-4,562
Investments in subsidiaries68,96927,54452,03517,1158,117-(173,780)-
Intercompany receivables-4,505-7,4252,33524,882(39,147)-
Goodwill --31,049--13,456-44,505
Other intangible assets--8,40018,9627,0404,601-39,003
Other assets48198-68741,488(246)1,630
Separate account assets-----7,839-7,839
TOTAL ASSETS$69,274$32,316$92,117$50,561$18,314$104,027$(213,383)$153,226
Liabilities
Current insurance and contractholder liabilities$-$-$-$-$-$6,801$-$6,801
Pharmacy and service costs payable---8,4221,579701-10,702
Accounts payable22--83443,506-4,366
Accrued expenses and other liabilities3961821291,3871894,998(210)7,071
Short-term debt-1,500995353-107-2,955
Total current liabilities4181,6821,12410,9961,77216,113(210)31,895
Non-current insurance and contractholder liabilities-----19,974-19,974
Deferred tax liabilities, net--2,0015,0121,6851,001(246)9,453
Other non-current liabilities-685-4972901,998-3,470
Intercompany payables4,9654,36129,569--252(39,147)-
Long-term debt22,8635,11010,9322450688-39,523
Separate account liabilities-----7,839-7,839
TOTAL LIABILITIES28,24611,83843,62616,5294,25347,265(39,603)112,154
Redeemable noncontrolling interests-----37-37
TOTAL SHAREHOLDERS’ EQUITY41,02820,47848,49134,03214,06156,718(173,780)41,028
Noncontrolling interests-----7-7
TOTAL EQUITY41,02820,47848,49134,03214,06156,725(173,780)41,035
TOTAL LIABILITIES AND EQUITY$69,274$32,316$92,117$50,561$18,314$104,027$(213,383)$153,226

Condensed Consolidating Balance Sheets
(In millions)
As of December 31, 2017CignaOld CignaExpress Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Assets
Cash and cash equivalents$-$9$-$-$-$2,963$-$2,972
Investments-63---2,073-2,136
Accounts receivable, net-----3,155-3,155
Inventories-----228-228
Other current assets-31---789-820
Total current assets-103---9,208-9,311
Long-term investments-----26,483-26,483
Reinsurance recoverables-----5,763-5,763
Deferred policy acquisition costs-----2,237-2,237
Property and equipment-----1,563-1,563
Investments in subsidiaries-22,631----(22,631)-
Intercompany receivables-200---2,980(3,180)-
Deferred tax assets, net-221---(182)-39
Goodwill -----6,164-6,164
Other intangible assets-----345-345
Other assets-----1,431-1,431
Separate account assets-----8,423-8,423
TOTAL ASSETS$-$23,155$-$-$-$64,415$(25,811)$61,759
Liabilities
Current insurance and contractholder liabilities-----6,317-6,317
Pharmacy and service costs payable-----305-305
Accounts payable, accrued expenses and other liabilities-270---3,877-4,147
Short-term debt-231---9-240
Total current liabilities-501---10,508-11,009
Non-current insurance and contractholder liabilities-----20,530-20,530
Intercompany payables-2,980---200(3,180)-
Other non-current liabilities-851---1,987-2,838
Long-term debt-5,112---87-5,199
Separate account liabilities-----8,423-8,423
TOTAL LIABILITIES-9,444---41,735(3,180)47,999
Redeemable noncontrolling interests-----49-49
SHAREHOLDERS’ EQUITY-13,711---22,631(22,631)13,711
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$-$23,155$-$-$-$64,415$(25,811)$61,759
Condensed Consolidating Cash Flow Statements
Condensed Consolidating Cash Flow Statements
(In millions)
For the year ended December 31, 2018CignaOld Cigna Express Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Net cash provided by (used in) operating activities $ 145 $ 2,416 $ (36) $ 80 $ (304) $ 3,987 $ (2,518) $ 3,770
Cash Flows from Investing Activities
Net change in loans due (from) affiliates-(4,412)(200)--(1,121)5,733-
Proceeds from investments sold:
Fixed maturities and equity securities-----2,655-2,655
Investment maturities and repayments:
Fixed maturities and equity securities-----2,151-2,151
Commercial mortgage loans-----215-215
Other sales, maturities and repayments (primarily short-term and other long-term investments) -63---671-734
Investments purchased or originated:
Fixed maturities and equity securities-(10)---(5,627)-(5,637)
Commercial mortgage loans-----(312)-(312)
Other sales, maturities and repayments (primarily short-term and other long-term investments) -----(1,189)-(1,189)
Property and equipment purchases, net---(6)-(522)-(528)
Acquisitions, net of cash acquired(27,115)-1,67623-961-(24,455)
Other, net-----(12)-(12)
NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES (27,115)(4,359)1,47617-(2,130)5,733(26,378)
Cash Flows from Financing Activities
Net change in amounts due to (from) affiliates4,4371,121(807)(54)304732(5,733)-
Intercompany dividends paid-----(2,518)2,518-
Deposits and interest credited to contractholder deposit funds-----1,040-1,040
Withdrawals and benefit payments from contractholder deposit funds-----(1,151)-(1,151)
Net change in short-term debt-1,400---87-1,487
Payments for debt extinguishment--------
Repayment of long-term debt-(131)-----(131)
Net proceeds on issuance of long-term debt22,856------22,856
Repurchase of common stock(32)(310)-----(342)
Issuance of common stock167-----68
Other, net (49)(213)---(50)-(312)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES27,2131,934(807)(54)304(1,860)(3,215)23,515
Effect of foreign currency rate changes on cash and cash equivalents-----(24)-(24)
Net increase (decrease) in cash and cash equivalents243(9)63343-(27)-883
Cash and cash equivalents, January 1,-9---2,963-2,972
Cash and cash equivalents, December 31,$243$-$633$43$-$2,936$-$3,855

Condensed Consolidating Cash Flow Statements
(In millions)
For the year ended December 31, 2017CignaOld Cigna Express Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Net cash provided by operating activities $ - $ 602 $ - $ - $ - $ 4,242 $ (758) $ 4,086
Cash Flows from Investing Activities
Net change in loans due (from) affiliates-----(1,955)1,955-
Proceeds from investments sold:
Fixed maturities and equity securities-----2,012-2,012
Investment maturities and repayments:
Fixed maturities and equity securities-----2,051-2,051
Commercial mortgage loans-----335-335
Other sales, maturities and repayments (primarily short-term and other long-term investments) -----1,702-1,702
Investments purchased or originated:
Fixed maturities and equity securities-----(5,628)-(5,628)
Commercial mortgage loans-----(430)-(430)
Other sales, maturities and repayments (primarily short-term and other long-term investments) -(6)---(1,059)-(1,065)
Property and equipment purchases, net-----(471)-(471)
Acquisitions, net of cash acquired-----(209)-(209)
Other, net-(11)---11--
NET CASH (USED IN) INVESTING ACTIVITIES -(17)---(3,641)1,955(1,703)
Cash Flows from Financing Activities
Net change in amounts due to affiliates-1,955----(1,955)-
Intercompany dividends paid-----(758)758-
Deposits and interest credited to contractholder deposit funds-----1,230-1,230
Withdrawals and benefit payments from contractholder deposit funds-----(1,363)-(1,363)
Net change in short-term debt-100---(20)-80
Payments for debt extinguishment-(313)-----(313)
Repayment of long-term debt-(1,250)-----(1,250)
Net proceeds on issuance of long-term debt-1,581-----1,581
Repurchase of common stock-(2,725)-----(2,725)
Issuance of common stock-131-----131
Other, net -(73)---51-(22)
NET CASH (USED IN) FINANCING ACTIVITIES-(594)---(860)(1,197)(2,651)
Effect of foreign currency rate changes on cash and cash equivalents-----55-55
Net decrease in cash and cash equivalents-(9)---(204)-(213)
Cash and cash equivalents, January 1,-18---3,167-3,185
Cash and cash equivalents, December 31,$-$9$-$-$-$2,963$-$2,972

Condensed Consolidating Cash Flow Statements
(In millions)
For the year ended December 31, 2016CignaOld Cigna Express Scripts Holding CompanyExpress Scripts, Inc.Medco Health Solutions, Inc.Non-GuarantorsEliminations and Consolidation AdjustmentsConsolidated
Net cash provided by operating activities $ - $ 376 $ - $ - $ - $ 4,230 $ (580) $ 4,026
Cash Flows from Investing Activities
Net change in loans due to affiliates-----78(78)-
Proceeds from investments sold:
Fixed maturities and equity securities-----1,544-1,544
Investment maturities and repayments:
Fixed maturities and equity securities-----1,755-1,755
Commercial mortgage loans-----316-316
Other sales, maturities and repayments (primarily short-term and other long-term investments) -----1,431-1,431
Investments purchased or originated:
Fixed maturities and equity securities-----(5,191)-(5,191)
Commercial mortgage loans-----(165)-(165)
Other sales, maturities and repayments (primarily short-term and other long-term investments) -(3)---(1,695)-(1,698)
Property and equipment purchases, net-----(461)-(461)
Acquisitions, net of cash acquired-----(4)-(4)
Other, net-(8)---(93)-(101)
NET CASH (USED IN) INVESTING ACTIVITIES -(11)---(2,485)(78)(2,574)
Cash Flows from Financing Activities
Net change in amounts due (from) affiliates-(78)----78-
Intercompany dividends paid-----(580)580-
Deposits and interest credited to contractholder deposit funds-----1,460-1,460
Withdrawals and benefit payments from contractholder deposit funds-----(1,362)-(1,362)
Net change in short-term debt-(100)---(48)-(148)
Payments for debt extinguishment--------
Repayment of long-term debt--------
Net proceeds on issuance of long-term debt--------
Repurchase of common stock-(139)-----(139)
Issuance of common stock-36-----36
Other, net -(82)---10-(72)
NET CASH (USED IN) FINANCING ACTIVITIES-(363)---(520)658(225)
Effect of foreign currency rate changes on cash and cash equivalents-----(10)-(10)
Net increase in cash and cash equivalents-2---1,215-1,217
Cash and cash equivalents, January 1,-16---1,952-1,968
Cash and cash equivalents, December 31,$-$18$-$-$-$3,167$-$3,185